反应详情

Following general procedure II, 1-(6-chloro-4-{6-[2-(dimethylamino)ethoxy]pyridin-3-ylamino}-1,5-naphthyridin-3-yl)ethanone (50 mg, 0.13 mmol) was reacted with 2,6-dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (56 mg, 0.20 mmol) followed by formation of the dihydrochloride salt to afford the desired product (63 mg, 83%) as a yellow-orange solid: 1H NMR (500 MHz, CD3OD) δ 9.35 (s, 1H), 8.46 (d, J=9.0 Hz, 1H), 8.37 (d, J=9.0 Hz, 1H), 8.24 (d, J=2.7 Hz, 1H), 7.78 (dd, J=8.8, 2.7 Hz, 1H), 7.44 (br s, 2H), 7.02 (d, J=8.8 Hz, 1H), 4.72-4.66 (m, 2H), 3.64-3.58 (m, 2H), 3.00 (s, 6H), 2.84 (s, 3H); ESI MS m/z 512 [M+H]+; HPLC 99% (AUC), tR=9.73 min.